ENStem cell clinics in Germany are sought for two very different reasons. Some people need a bone marrow transplant their own country cannot arrange; others have read that an injection of their own cells at a stem cell clinic in Germany can repair a knee, a spinal cord or a damaged brain.
This page keeps the two worlds apart, because the rules, the evidence and the money differ. The word “Germany” on a website is not in itself a guarantee.
Two kinds of stem cell clinic
German stem cell clinics are of two kinds. The first are transplant centres in university and large hospitals, using the patient’s or a donor’s blood stem cells for leukaemia, lymphoma, myeloma and aplastic anaemia: regulated medicine with decades of records, donor registries and intensive care next door. Examples are the UKE in Hamburg, which has a stem cell transplantation department; Essen University Hospital, with its Department of Haematology and Stem Cell Transplantation; Klinikum Stuttgart, where transplants are a main focus of haematology; and Klinikum Nürnberg, which uses related and unrelated donors.
The second are private clinics offering injections of cells from the patient’s own fat or bone marrow for arthritis, multiple sclerosis, autism, cerebral palsy or “regeneration”: self-pay services that health insurers generally do not reimburse.
In practice, a transplant centre is chosen by disease and department, a private clinic by its claim, which calls for different questions. More in the article on stem cell therapy: what is proven.
What German law actually allows
German law treats a cell preparation as a medicinal product, not a surgical procedure: making it needs a state licence, marketing it needs approval. Tissue returned unchanged to the same patient during one procedure falls outside the Medicinal Products Act, so it is never assessed as a medicine.
The Paul-Ehrlich-Institut, the federal institute for vaccines and biomedicines, is responsible for cell and gene medicines in Germany; EU approval comes from the European Commission, often with the institute leading the assessment. Few cell-based products are approved; everything else is an approved trial or an exception for an individual patient, authorised by the institute. Heidelberg University Hospital was the first academic institution in Germany to receive such an authorisation, for its own CAR-T cells in chronic lymphocytic leukaemia.
So “we are a licensed German clinic” may mean a hospital licence, not an approved preparation: ask which preparation is used and under which permission. A Paul-Ehrlich-Institut warning lists other red flags: a promised cure for a serious illness without scientific evidence, paid “experimental therapies” outside approved trials, high costs not reimbursed by insurers. See also whether stem cell therapy is legal in Germany.
Proven, experimental, and marketed
Proven means transplantation of blood-forming stem cells for defined blood diseases, indicated by a board of haematologists rather than on request; see haematology treatment in Germany. CAR-T cell therapy, which re-engineers the patient’s own immune cells to attack a tumour, is a separate approved technology for narrow indications: certain leukaemias, lymphomas and myeloma, usually after relapse or failed treatment.
Experimental means trials in heart failure, spinal cord injury, type 1 diabetes and neurological diseases such as Parkinson’s. A genuine trial has a protocol, a registry number and no invoice for the therapy: under EU rules participants normally pay neither for the investigational product nor for procedures the protocol requires — the honest marker of a study.
Marketed means offers to treat knee arthritis, multiple sclerosis or autism with a single injection. The evidence does not support these claims: in trials, a single infusion of umbilical cord blood did not reduce the symptoms of autism, mesenchymal cells missed their main goal in multiple sclerosis, and cell injections into an arthritic knee may at most ease pain rather than restore the joint. Paying more does not change that.
Six questions to ask a clinic in Germany
Before paying a stem cell clinic in Germany, ask six questions and get the answers in writing.
- What exactly is injected, and were the cells grown in a laboratory?
- Under which licence or approval is it used?
- Is this a registered clinical trial, and what is its number?
- Who treats complications, and in which hospital?
- What does the written estimate cover, and what not?
- What does an independent specialist in the field say about the indication?
A clinic that answers in writing is telling you something; one that answers with testimonials is telling you something too. For an example, see the Villa Medica clinic page.
What it costs and why price proves nothing
Price says nothing about benefit. A transplant is priced as a hospital stay with a defined protocol; private cell injections are usually priced per session or course, at a figure the clinic sets itself.
Before paying, check that the estimate lists diagnostics, the preparation, the stay and follow-up separately, and what happens to the money if the board decides against treatment. See also the cost of stem cell treatment in Germany.
Frequently asked questions
How can I check that a clinic is offering a genuine clinical trial?
Ask for the trial number and look it up in a public registry such as the German Clinical Trials Register (DRKS) or ClinicalTrials.gov. If there is no number, or the clinic charges for the investigational product, be careful: under EU rules participants normally do not pay for it.
Do clinics in Germany treat multiple sclerosis with stem cells?
Not with a single injection of cells, which failed in a trial. Transplanting the patient’s own blood stem cells after chemotherapy is different: the European Society for Blood and Marrow Transplantation (EBMT) considers this heavy treatment for highly active relapsing MS that has not responded to disease-modifying drugs. Other cell therapies, the society advises, belong in clinical trials only.
Where can I see which cell-based medicines are approved in Germany?
On the website of the Paul-Ehrlich-Institut, which publishes information on approved advanced therapy medicinal products. If the product a clinic offers is not there, ask which approved trial or individual authorisation covers it. A clinic’s own licence and its doctors’ diplomas do not answer that question.
How AlenMed arranges treatment
AlenMed reviews the documents remotely and asks a haematology or specialist department whether cell-based treatment is indicated at all. Only then are the hospital, dates, official estimate, visa invitation and interpreter arranged.
The patient receives in writing the indication, the protocol and the follow-up plan. Where the evidence is missing, we say so rather than arrange the trip.
This material is for information only and is not an offer; a doctor decides on treatment at an in-person consultation.